IRF4 Has a Unique Role in Early B Cell Development and Acts Prior to CD21 Expression to Control Marginal Zone B Cell Numbers
Open Access
- 22 November 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12
Abstract
Strict control of B lymphocyte development is required for the ability to mount humoral immune responses to diverse foreign antigens while remaining self-tolerant. In the bone marrow, B lineage cells transit through several developmental stages in which they assemble a functional B cell receptor in a stepwise manner. The immunoglobulin heavy chain gene is rearranged at the pro-B stage. At the large pre-B stage, cells with a functional heavy chain expand in response to signals from IL-7 and the pre-BCR. Cells then cease proliferation at the small pre-B stage and rearrange the immunoglobulin light chain gene. The fully formed BCR is subsequently expressed on the surface of immature B cells and autoreactive cells are culled by central tolerance mechanisms. Once in the periphery, transitional B cells develop into mature B cell subsets such as marginal zone and follicular B cells. These developmental processes are controlled by transcription factor networks, central to which are IRF4 and IRF8. These were thought to act redundantly during B cell development in the bone marrow, with their functions diverging in the periphery where IRF4 limits the number of marginal zone B cells and is required for germinal center responses and plasma cell differentiation. Because of IRF4’s unique role in mature B cells, we hypothesized that it may also have functions earlier in B cell development that cannot be compensated for by IRF8. Indeed, we find that IRF4 has a unique role in upregulating the pre-B cell marker CD25, limiting IL-7 responsiveness, and promoting migration to CXCR4 such that IRF4-deficient mice have a partial block at the pre-B cell stage. We also find that IRF4 acts in early transitional B cells to restrict marginal zone B cell development, as deletion of IRF4 in mature B cells with CD21-cre impairs plasma cell differentiation but has no effect on marginal zone B cell numbers. These studies highlight IRF4 as the dominant IRF family member in early B lymphopoiesis.Keywords
Funding Information
- National Institutes of Health (AI137746)
This publication has 25 references indexed in Scilit:
- Foxo1 regulates marginal zone B‐cell developmentEuropean Journal of Immunology, 2010
- ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivoJournal of Experimental Medicine, 2010
- Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signallingNature Reviews Immunology, 2009
- SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathwayNature Immunology, 2008
- Transcription factor IRF4 controls plasma cell differentiation and class-switch recombinationNature Immunology, 2006
- Survival of Resting Mature B Lymphocytes Depends on BCR Signaling via the Igα/β HeterodimerCell, 2004
- IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte developmentGenes & Development, 2003
- Notch2 Is Preferentially Expressed in Mature B Cells and Indispensable for Marginal Zone B Lineage DevelopmentImmunity, 2003
- The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansionNature Immunology, 2002
- Control of Pre-BCR Signaling by Pax5-Dependent Activation of the BLNK GeneImmunity, 2002